Clinical Trial Update: Safety and Efficacy Study of Istaroxime in Acute Decompensated Heart Failure Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating istaroxime for acute decompensated heart failure was withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure

Drugs mentioned

• Istaroxime (istaroxime)

Snippet

Sponsor: Debiopharm International SA | Conditions: Heart Failure | Phase 2 | Status: WITHDRAWN